19064-24-5Relevant articles and documents
Pseudocyclic bis-N-heterocycle-stabilized iodanes - synthesis, characterization and applications
Boelke, Andreas,Lork, Enno,Nachtsheim, Boris J.,Sadat, Soleicha
supporting information, p. 7434 - 7437 (2021/08/03)
Bis-N-heterocycle-stabilized λ3-iodanes (BNHIs) based on azoles are introduced as novel structural motifs in hypervalent iodine chemistry. A performance test in a variety of benchmark reactions including sulfoxidations and phenol dearomatizations revealed a bis-N-bound pyrazole substituted BNHI as the most reactive derivative. Its solid-state structure was characterizedviaX-ray analysis implying strong intramolecular interactions between the pyrazole nitrogen atoms and the hypervalent iodine centre.
DIHYDROBENZOFURANYL DERIVATIVES AND METHODS OF THEIR USE
-
Page/Page column 20, (2008/12/06)
The present invention is directed to dihydrobenzofuranyl derivatives of formula I: or a pharmaceutically acceptable salt thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorder, cognitive disorder, diabetic neuropathy, pain, and other diseases or disorders.
Progesterone receptor antagonists, contraceptive regimens, and kits
-
Page/Page column 8, (2010/02/15)
A method of contraception is provided which involves delivery of 21 to 27 consecutive days of one or more PR antagonists in the absence of a progestin, estrogen, or other steroidal compound, followed by 1 to 7 days without any active agent. Also described is a pharmaceutically useful kit to facilitate delivery of this regimen.